Literature DB >> 19928862

Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.

Michael Decker1, Yu-Gui Si, Brian I Knapp, Jean M Bidlack, John L Neumeyer.   

Abstract

The phenolic group of the potent mu and kappa opioid morphinan agonist/antagonists cyclorphan and butorphan was replaced by phenylamino and benzylamino groups including compounds with para-substituents in the benzene ring. These compounds are highly potent mu and kappa ligands, e.g., p-methoxyphenylaminocyclorphan showing a K(i) of 0.026 nM at the mu receptor and a K(i) of 0.03 nM at the kappa receptor. Phenyl carbamates and phenylureas were synthesized and investigated. Selective o-formylation of butorphan and levorphanol was achieved. This reaction opened the way to a large set of 2-substituted 3-hydroxymorphinans, including 2-hydroxymethyl-, 2-aminomethyl-, and N-substituted 2-aminomethyl-3-hydroxymorphinans. Bivalent ligands bridged in the 2-position were also synthesized and connected with secondary and tertiary aminomethyl groups, amide bonds, and hydroxymethylene groups, respectively. Although most of the 2-substituted morphinans showed considerably lower affinities compared to their parent compounds, the bivalent ligand approach led to significantly higher affinities compared to the univalent 2-substituted morphinans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19928862      PMCID: PMC2814335          DOI: 10.1021/jm9013482

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.

Authors:  J L Neumeyer; J M Bidlack; R Zong; V Bakthavachalam; P Gao; D J Cohen; S S Negus; N K Mello
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

2.  Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.

Authors:  Mark P Wentland; Melissa VanAlstine; Robert Kucejko; Rongliang Lou; Dana J Cohen; Amy L Parkhill; Jean M Bidlack
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

3.  Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.

Authors:  Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

4.  High-affinity carbamate analogues of morphinan at opioid receptors.

Authors:  Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  Bioorg Med Chem Lett       Date:  2007-01-17       Impact factor: 2.823

Review 5.  Narcotic and narcotic antagonist analgesics.

Authors:  H F Fraser; L S Harris
Journal:  Annu Rev Pharmacol       Date:  1967       Impact factor: 13.820

6.  8-Aminocyclazocine analogues: synthesis and structure-activity relationships.

Authors:  M P Wentland; G Xu; C L Cioffi; Y Ye; W Duan; D J Cohen; A M Colasurdo; J M Bidlack
Journal:  Bioorg Med Chem Lett       Date:  2000-01-17       Impact factor: 2.823

7.  Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.

Authors:  V I Chefer; J A Morón; B Hope; W Rea; T S Shippenberg
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors.

Authors:  Xuemei Peng; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  Bioorg Med Chem       Date:  2007-03-30       Impact factor: 3.641

9.  Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse.

Authors:  J L Neumeyer; N K Mello; S S Negus; J M Bidlack
Journal:  Pharm Acta Helv       Date:  2000-03

10.  Selective protection and functionalization of morphine: synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives.

Authors:  M P Wentland; W Duan; D J Cohen; J M Bidlack
Journal:  J Med Chem       Date:  2000-09-21       Impact factor: 7.446

View more
  6 in total

1.  Synthesis and biological evaluation of arylated novobiocin analogs as Hsp90 inhibitors.

Authors:  Bhaskar Reddy Kusuma; Adam S Duerfeldt; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2011-10-01       Impact factor: 2.823

2.  Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.

Authors:  John L Neumeyer; Bin Zhang; Tangzhi Zhang; Anna W Sromek; Brian I Knapp; Dana J Cohen; Jean M Bidlack
Journal:  J Med Chem       Date:  2012-04-04       Impact factor: 7.446

3.  Preliminary pharmacological evaluation of enantiomeric morphinans.

Authors:  Anna W Sromek; Brian A Provencher; Shayla Russell; Elena Chartoff; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  ACS Chem Neurosci       Date:  2014-01-08       Impact factor: 4.418

4.  Rapid access to morphinones: removal of 4, 5-ether bridge with Pd-catalyzed triflate reduction.

Authors:  Christopher D Hupp; John L Neumeyer
Journal:  Tetrahedron Lett       Date:  2010-04-28       Impact factor: 2.415

Review 5.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 6.  Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions.

Authors:  Paula Ruiz-Castillo; Stephen L Buchwald
Journal:  Chem Rev       Date:  2016-09-30       Impact factor: 60.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.